Heart Attack News and Research

RSS

New driver of atherosclerosis may prove to be promising therapeutic target

A new driver of atherosclerosis has been identified by researchers at UT Southwestern Medical Center. This molecule, known as 27HC (27-hydroxycholesterol), has been found to exacerbate the development of the condition, and may prove to be a promising therapeutic target.

20 Jun 2014

Counseling, medication management by pharmacist can lower hospital readmissions

Getting discharged from the hospital and then having to go right back in again can be emotionally draining for a patient and their family. It can also cause financial strain for all involved - the patient, the hospital system and the insurers-including Medicaid and Medicare, which are taxpayer funded.

19 Jun 2014

Genetic variants linked to race that explains risk of death among patients taking Plavix after heart attack

Researchers have identified the first genetic variations linked to race that begin to explain a higher risk of death among some African American and Caucasian patients taking the anti-clotting drug clopidogrel (Plavix) after a heart attack.

18 Jun 2014

AADE recommends easy-to-follow tips for diabetes management

"You have Type 2 diabetes." When you deliver this news to patients, many are surprised, even shocked. Research shows some are so busy processing this unwelcome information, they have a difficult time focusing on what you are saying - and about a fourth of them wonder whether it's even true.

18 Jun 2014

OHS performs clinical drug trial to reduce cholesterol levels with just one injection

Research One, Inc., an affiliate of Orlando Heart Specialists (OHS), is seeking candidates for a clinical drug trial that could reduce cholesterol levels with just one injection, twice a month.

17 Jun 2014

Neuroscientist receives national biomedical research mentoring award

University of Alaska Fairbanks neuroscientist Kelly Drew will receive a national biomedical research mentoring award from the National Institutes of Health, Institutional Development Awards program in Washington, D.C. June 17.

17 Jun 2014

Lowering systolic blood pressure below 120 does not appear to provide additional benefit

For decades, common medical wisdom has been "the lower the better" in treating the approximately one in three people in this country who have high blood pressure.

17 Jun 2014

Study: Use of stem cells to regenerate heart muscle in patients who have heart attacks

Stem cell therapy for cardiovascular disease isn't a medical pipe dream - it's a reality today, although patients need to better understand the complex science behind these experimental treatments, according to the chief of Cardiology for the Cedars-Sinai Heart Institute.

17 Jun 2014

Using placental cells to repair damaged tissues: an interview with Zami Aberman, CEO, Pluristem Therapeutics

We start with birth and we collect the cells after C-section. The reason for that is we have to have the mother sign a consent letter that she is donating the placenta and, on top of that, we have to have a blood sample from the mother to test for any viral contamination.

16 Jun 2014

Study shows significantly increased risk of heart attack in patients with Sj-gren's syndrome

A new study presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) showed a significantly increased risk of heart attack in patients with Sj-gren's syndrome (SjS), particularly in the first year following diagnosis.

13 Jun 2014

Bacteria must be considered part of overall pathology of atherosclerosis

Scientists believe they have an explanation for the axiom that stress, emotional shock, or overexertion may trigger heart attacks in vulnerable people. Hormones released during these events appear to cause bacterial biofilms on arterial walls to disperse, allowing plaque deposits to rupture into the bloodstream, according to research published in published today in mBio-, the online open-access journal of the American Society for Microbiology.

11 Jun 2014

Type 2 diabetes Patients who take metformin plus insulin at higher risk for heart disease, death

Patients with type 2 diabetes who take a combination of metformin plus insulin may be at higher risk for cardiovascular disease and death compared with those who take a combination of metformin plus sulfonylurea, according to a new study funded by the Agency for Healthcare Research and Quality that appears in the June 11 issue of JAMA.

11 Jun 2014

Blood pressure has heterogeneous associations with cardiovascular diseases

The associations between blood pressure and cardiovascular disease are variable, reveals a large study that highlights the impact of angina and heart failure.

5 Jun 2014

Non-obstructive coronary artery disease linked with 28 to 44% increased risk of major heart attack

Non-obstructive coronary artery disease was associated with a 28 to 44 percent increased risk of a major adverse cardiac event such as a heart attack or death, in a new study presented at the American Heart Association's Quality of Care and Outcomes Research 2014 Scientific Sessions.

5 Jun 2014

STENTYS signs agreement to acquire assets of Cappella Peel Away

STENTYS, a medical technology company commercializing in Europe the world's first and only Self-Apposing® Stent to treat acute myocardial infarction (AMI), today announced the signing of the acquisition agreement of Cappella Peel Away Inc. (Delaware, USA) and its assets relating to a novel stent delivery system. The acquisition is subject to closing conditions.

5 Jun 2014

Incyte’s ruxolitinib Phase III study for polycythemia vera achieves primary endpoint

Incyte Corporation (Nasdaq: INCY) today announced results from the RESPONSE trial, the first pivotal Phase III study evaluating a JAK1/JAK2 inhibitor for the treatment of polycythemia vera (PV).

4 Jun 2014

NeuroVive extends collaboration with Hospices Civils de Lyon

NeuroVive is extending its collaboration with Hospices Civils de Lyon (HCL) and Professor Ovize, which broadens the scope of NeuroVive's cardiovascular business area and creates the right conditions for the company to retain its leading position in mitochondrial medicine.

4 Jun 2014

P2Y12 and blood clotting: an interview with Dr. Jacobson, NIH

We already understand the many steps involved in blood clotting in great mechanistic detail. The process of blood vessels closing off in response to injury is necessary for preserving life, but blood platelets that are over-active, or activated inappropriately because of unstable plaque, can lead to heart attacks and strokes.

3 Jun 2014

Experts from ProfNet network available to discuss timely issues in coverage area

Below are experts from the ProfNet network that are available to discuss timely issues in your coverage area. If you are interested in interviewing any of the experts, please contact them via the contact information at the end of the listing.

31 May 2014

Significant advances in hypertension management prevent major cardiovascular events

Hypertension (raised blood pressure) treatment rates have almost doubled and control rates have trebled in England between 1994 and 2011, resulting in the saving of tens of thousands of lives each year, according to a new study published in a special themed issue of The Lancet.

31 May 2014

Heart Attack News and Research

New driver of atherosclerosis may prove to be promising therapeutic target

Counseling, medication management by pharmacist can lower hospital readmissions

Genetic variants linked to race that explains risk of death among patients taking Plavix after heart attack

AADE recommends easy-to-follow tips for diabetes management

OHS performs clinical drug trial to reduce cholesterol levels with just one injection

Neuroscientist receives national biomedical research mentoring award

Lowering systolic blood pressure below 120 does not appear to provide additional benefit

Study: Use of stem cells to regenerate heart muscle in patients who have heart attacks

Using placental cells to repair damaged tissues: an interview with Zami Aberman, CEO, Pluristem Therapeutics

Study shows significantly increased risk of heart attack in patients with Sj-gren's syndrome

Bacteria must be considered part of overall pathology of atherosclerosis

Type 2 diabetes Patients who take metformin plus insulin at higher risk for heart disease, death

Blood pressure has heterogeneous associations with cardiovascular diseases

Non-obstructive coronary artery disease linked with 28 to 44% increased risk of major heart attack

STENTYS signs agreement to acquire assets of Cappella Peel Away

Incyte’s ruxolitinib Phase III study for polycythemia vera achieves primary endpoint

NeuroVive extends collaboration with Hospices Civils de Lyon

P2Y12 and blood clotting: an interview with Dr. Jacobson, NIH

Experts from ProfNet network available to discuss timely issues in coverage area

Significant advances in hypertension management prevent major cardiovascular events

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News